Your request to link to rcsb for Dipeptidyl peptidase 4

---

• 1J2E: crystal structure of human dipeptidyl peptidase iv (10.1016/S0006-291X(03)00258-4 )
• 1N1M: human dipeptidyl peptidase iv/cd26 in complex with an inhibitor (10.1038/NSB882 )
• 1NU6: crystal structure of human dipeptidyl peptidase iv (dpp-iv) (10.1016/S0969-2126(03)00160-6 )
• 1NU8: crystal structure of human dipeptidyl peptidase iv (dpp-iv) in complex with diprotin a (ipi) 24-aug-16 1nu8 1 title (10.1016/S0969-2126(03)00160-6 )
• 1ORV: crystal structure of porcine dipeptidyl peptidase iv (cd26) (10.1073/PNAS.0230620100 )
• 1ORW: crystal structure of porcine dipeptidyl peptidase iv (cd26) in complex with a peptidomimetic inhibitor (10.1073/PNAS.0230620100 )
• 1PFQ: crystal structure of human apo dipeptidyl peptidase iv / cd26 (10.1107/S0907444903010059 )
• 1R9M: crystal structure of human dipeptidyl peptidase iv at 2.1 ang. resolution. (10.1110/PS.03460604 )
• 1R9N: crystal structure of human dipeptidyl peptidase iv in complex with a decapeptide (tnpy) at 2.3 ang. resolution (10.1110/PS.03460604 )
• 1RWQ: human dipeptidyl peptidase iv in complex with 5-aminomethyl-6-(2,4- dichloro-phenyl)-2-(3,5-dimethoxy-phenyl)-pyrimidin-4-ylamine (10.1016/J.BMCL.2004.01.019 )
• 1TK3: crystal structure of human apo dipeptidyl peptidase iv/cd26 (10.1074/JBC.M405400200 )
• 1TKR: human dipeptidyl peptidase iv/cd26 inhibited with diisopropyl fluorophosphate (10.1074/JBC.M405400200 )
• 1U8E: human dipeptidyl peptidase iv/cd26 mutant y547f (10.1074/JBC.M405400200 )
• 1W1I: crystal structure of dipeptidyl peptidase iv (dppiv or cd26) in complex with adenosine deaminase (10.1074/JBC.M405001200 )
• 1WCY: crystal structure of human dipeptidyl peptidase iv (dppiv) complex with diprotin a (10.1515/BC.2004.068 )
• 1X70: human dipeptidyl peptidase iv in complex with a beta amino acid inhibitor (10.1021/JM0493156 )
• 2AJ8: porcine dipeptidyl peptidase iv (cd26) in complex with 7-benzyl-1,3- dimethyl-8-piperazin-1-yl-3,7-dihydro-purine-2,6-dione (bdpx) (10.1016/J.JMB.2005.11.014 )
• 2AJB: porcine dipeptidyl peptidase iv (cd26) in complex with the tripeptide tert-butyl-gly-l-pro-l-ile (tbu-gpi) (10.1016/J.JMB.2005.11.014 )
• 2AJC: porcine dipeptidyl peptidase iv (cd26) in complex with 4-(2- aminoethyl)-benzene sulphonyl fluoride (aebsf) (10.1016/J.JMB.2005.11.014 )
• 2AJD: porcine dipeptidyl peptidase iv (cd26) in complex with l-pro-boro-l- pro (boropro) (10.1016/J.JMB.2005.11.014 )
• 2AJL: x-ray structure of novel biaryl-based dipeptidyl peptidase iv inhibitor (10.1016/J.BMCL.2005.09.037 )
• 2BGN: hiv-1 tat protein derived n-terminal nonapeptide trp2-tat(1-9) bound to the active site of dipeptidyl peptidase iv (cd26) (10.1074/JBC.M413400200 )
• 2BGR: crystal structure of hiv-1 tat derived nonapeptides tat(1-9) bound to the active site of dipeptidyl peptidase iv (cd26) (10.1074/JBC.M413400200 )
• 2BUA: crystal structure of porcine dipeptidyl peptidase iv (cd26) in complex with a low molecular weight inhibitor. (10.1016/J.BMCL.2005.11.103 )
• 2BUB: crystal structure of human dipeptidyl peptidase iv (cd26) in complex with a reversed amide inhibitor (10.1016/J.BMCL.2005.11.103 )
• 2BUC: crystal structure of porcine dipeptidyl peptidase iv (cd26) in complex with a tetrahydroisoquinoline inhibitor 24-apr-06 2buc 1 title (10.1016/J.BMCL.2005.11.103 )
• 2FJP: human dipeptidyl peptidase iv/cd26 in complex with an inhibitor (10.1021/JM060015T )
• 2G5P: crystal structure of human dipeptidyl peptidase iv (dppiv) complexed with cyanopyrrolidine (c5-pro-pro) inhibitor 21ac (10.1021/JM051283E )
• 2G5T: crystal structure of human dipeptidyl peptidase iv (dppiv) complexed with cyanopyrrolidine (c5-pro-pro) inhibitor 21ag (10.1021/JM051283E )
• 2G63: crystal structure of human dipeptidyl peptidase iv (dppiv) complexed with cyanopyrrolidine (c5-pro-pro) inhibitor 24b (10.1021/JM051283E )
• 2GBC: native dpp-iv (cd26) from rat (10.1021/BI060184F )
• 2GBF: rat dpp-iv with alkynyl cyanopyrrolidine #1 (10.1021/BI060184F )
• 2GBG: rat dpp-iv with alkynyl cyanopyrrolidine #2 (10.1021/BI060184F )
• 2GBI: rat dpp-iv with xanthine inhibitor 4 (10.1021/BI060184F )
• 2HHA: the structure of dpp4 in complex with an oxadiazole inhibitor (10.1016/J.BMCL.2006.07.061 )
• 2I03: crystal structure of human dipeptidyl peptidase 4 (dpp iv) with potent alkynyl cyanopyrrolidine (abt-279) (10.1021/JM060777O )
• 2I3Z: rat dpp-iv with xanthine mimetic inhibitor #7 (10.1016/J.BMCL.2006.09.024 )
• 2I78: crystal structure of human dipeptidyl peptidase iv (dpp iv) complexed with abt-341, a cyclohexene-constrained phenethylamine inhibitor
• 2IIT: human dipeptidyl peptidase 4 in complex with a diazepan-2-one inhibitor (10.1016/J.BMCL.2006.09.099 )
• 2IIV: human dipeptidyl peptidase 4 in complex with a diazepan-2-one inhibitor (10.1016/J.BMCL.2006.09.099 )
• 2JID: human dipeptidyl peptidase iv in complex with 1-(3,4-dimethoxy-phenyl) -3-m-tolyl-piperidine-4-ylamine (10.1016/J.BMCL.2007.03.072 )
• 2OAE: crystal structure of rat dipeptidyl peptidase (dppiv) with thiazole- based peptide mimetic #31 (10.1016/J.BMCL.2007.01.026 )
• 2OAG: crystal structure of human dipeptidyl peptidase iv (dppiv) with pyrrolidine-constrained phenethylamine 29g (10.1016/J.BMCL.2007.01.026 )
• 2OGZ: crystal structure of dpp-iv complexed with lilly aryl ketone inhibitor (10.1016/J.BMCL.2006.12.074 )
• 2OLE: crystal structure of human dipeptidyl peptidase iv (dppiv) complex with cyclic hydrazine derivatives (10.1016/J.BMCL.2007.01.111 )
• 2ONC: crystal structure of human dpp-4 (10.1021/JM070104L )
• 2OPH: human dipeptidyl peptidase iv in complex with an alpha amino acid inhibitor (10.1016/J.BMCL.2007.02.066 )
• 2OQI: human dipeptidyl peptidase iv (dpp4) with piperidinone-constrained phenethylamine (10.1021/JM061436D )
• 2OQV: human dipeptidyl peptidase iv (dpp4) with piperidine-constrained phenethylamine (10.1021/JM061436D )
• 2P8S: human dipeptidyl peptidase iv/cd26 in complex with a cyclohexalamine inhibitor (10.1016/J.BMCL.2007.03.095 )
• 2QJR: dipepdyl peptidase iv in complex with inhibitor pzf
• 2QKY: complex structure of dipeptidyl peptidase iv and a oxadiazolyl ketone (10.1016/J.BMCL.2007.05.046 )
• 2QOE: human dipeptidyl peptidase iv in complex with a triazolopiperazine- based beta amino acid inhibitor (10.1016/J.BMCL.2007.07.100 )
• 2QT9: human dipeptidyl peptidase iv/cd26 in complex with a 4-aryl cyclohexylalanine inhibitor (10.1016/J.BMCL.2007.08.049 )
• 2QTB: human dipeptidyl peptidase iv/cd26 in complex with a 4-aryl cyclohexylalanine inhibitor (10.1016/J.BMCL.2007.08.049 )
• 2RGU: crystal structure of complex of human dpp4 and inhibitor (10.1021/JM701280Z )
• 2RIP: structure of dppiv in complex with an inhibitor (10.1016/J.BMCL.2007.10.063 )
• 3BJM: crystal structure of human dpp-iv in complex with (1s,3s, 5s)-2-[(2s)- 2-amino-2-(3-hydroxytricyclo[3.3.1.13,7]dec-1- yl)acetyl]-2- azabicyclo[3.1.0]hexane-3-carbonitrile (cas), (1s,3s,5s)-2-((2s)-2- amino-2-(3-hydroxyadamantan-1- yl)acetyl)-2-azabicyclo[3.1.0]hexane- 3-carbonitrile (iupac), or bms-477118 (10.1110/PS.073253208 )
• 3C43: human dipeptidyl peptidase iv/cd26 in complex with a flouroolefin inhibitor (10.1016/J.BMCL.2008.02.050 )
• 3C45: human dipeptidyl peptidase iv/cd26 in complex with a fluoroolefin inhibitor (10.1016/J.BMCL.2008.02.050 )
• 3CCB: crystal structure of human dpp4 in complex with a benzimidazole derivative (10.1016/J.BMCL.2008.02.071 )
• 3CCC: crystal structure of human dpp4 in complex with a benzimidazole derivative (10.1016/J.BMCL.2008.02.071 )
• 3D4L: human dipeptidyl peptidase iv/cd26 in complex with a novel inhibitor (10.1016/J.BMCL.2008.05.061 )
• 3EIO: crystal structure analysis of dppiv inhibitor (10.1016/J.BMCL.2008.10.076 )
• 3F8S: crystal structure of dipeptidyl peptidase iv in complex with inhibitor (10.1016/J.BMCL.2009.02.041 )
• 3G0B: crystal structure of dipeptidyl peptidase iv in complex with tak-322 (10.1021/JM101016W )
• 3G0C: crystal structure of dipeptidyl peptidase iv in complex with a pyrimidinedione inhibitor 1 (10.1021/JM101016W )
• 3G0D: crystal structure of dipeptidyl peptidase iv in complex with a pyrimidinedione inhibitor 2 (10.1021/JM101016W )
• 3G0G: crystal structure of dipeptidyl peptidase iv in complex with a pyrimidinone inhibitor 3 (10.1021/JM101016W )
• 3H0C: crystal structure of human dipeptidyl peptidase iv (cd26) in complex with a reversed amide inhibitor
• 3HAB: the structure of dpp4 in complex with piperidine fused benzimidazole 25 (10.1016/J.BMCL.2009.06.011 )
• 3HAC: the structure of dpp-4 in complex with piperidine fused imidazopyridine 34 (10.1016/J.BMCL.2009.06.011 )
• 3KWF: human dpp-iv with carmegliptin (s)-1-((2s,3s,11bs)-2-amino-9,10- dimethoxy-1,3,4,6,7,11b-hexahydro-2h-pyrido[2,1-a]isoquinolin-3-yl)- 4-fluoromethyl-pyrrolidin-2-one (10.1016/J.BMCL.2009.12.024 )
• 3KWJ: structure of human dpp-iv with (2s,3s,11bs)-3-(3-fluoromethyl-phenyl)- 9,10-dimethoxy-1,3,4,6,7,11b-hexahydro-2h-pyrido[2,1-a]isoquinolin-2- ylamine (10.1016/J.BMCL.2009.12.025 )
• 3NOX: crystal structure of human dpp-iv in complex with sa-(+)-(6- (aminomethyl)-5-(2,4-dichlorophenyl)-7-methylimidazo[1,2-a]pyrimidin- 2-yl)(morpholino)methanone (10.1021/JM100634A )
• 3O95: crystal structure of human dpp4 bound to tak-100 (10.1021/JM101236H )
• 3O9V: crystal structure of human dpp4 bound to tak-986 (10.1021/JM101236H )
• 3OC0: structure of human dpp-iv with hts hit (2s,3s,11bs)-3-butyl-9,10- dimethoxy-1,3,4,6,7,11b-hexahydro-2h-pyrido[2,1-a]isoquinolin-2- ylamine (10.1016/J.BMCL.2009.12.024 )
• 3OPM: crystal structure of human dpp4 bound to tak-294 (10.1016/J.BMC.2011.06.059 )
• 3Q0T: crystal structure of human dpp-iv in complex withsa-(+)- methyl2-(3- (aminomethyl)-4-(2,4-dichlorophenyl)-2-methyl- 7-oxo-5h-pyrrolo[3,4- b]pyridin-6(7h)-yl)acetate
• 3Q8W: a b-aminoacyl containing thiazolidine derivative and dppiv complex
• 3QBJ: crystal structure of dipeptidyl peptidase iv in complex with inhibitor
• 3SWW: crystal structure of human dpp-iv in complex with sa-(+)-3- (aminomethyl)-4-(2,4-dichlorophenyl)-6-(2-methoxyphenyl)- 2-methyl- 5h-pyrrolo[3,4-b]pyridin-7(6h)-one (10.1016/J.BMCL.2011.09.074 )
• 3SX4: crystal structure of human dpp-iv in complex with sa-(+)-3- (aminomethyl)-4-(2,4-dichlorophenyl)-6-(2-methoxyphenyl)- 2-methyl- 5h-pyrrolo[3,4-b]pyridin-7(6h)-one (10.1016/J.BMCL.2011.09.074 )
• 3VJK: crystal structure of human depiptidyl peptidase iv (dpp-4) in complex with mp-513 (10.1016/J.BMC.2012.08.012 )
• 3VJL: crystal structure of human depiptidyl peptidase iv (dpp-4) in complex with a prolylthiazolidine inhibitor #2 (10.1016/J.BMC.2012.08.012 )
• 3VJM: crystal structure of human depiptidyl peptidase iv (dpp-4) in complex with a prolylthiazolidine inhibitor #1 (10.1016/J.BMC.2012.06.033 )
• 3W2T: crystal structure of human depiptidyl peptidase iv (dpp-4) in complex with vildagliptin (10.1016/J.BBRC.2013.03.010 )
• 3WQH: crystal structure of human dpp-iv in complex with anagliptin (10.3109/14756366.2014.1002402 )
• 4A5S: crystal structure of human dpp4 in complex with a noval heterocyclic dpp4 inhibitor (10.1016/J.BMCL.2011.11.054 )
• 4DSA: crystal structure of dpp-iv with compound c1
• 4DSZ: crystal structure of dpp-iv with compound c2
• 4DTC: crystal structure of dpp-iv with compound c5
• 4FFV: crystal structure of dipeptidyl peptidase iv (dpp4, dpp-iv, cd26) in complex with 11a19 fab
• 4FFW: crystal structure of dipeptidyl peptidase iv (dpp4, dpp-iv, cd26) in complex with fab + sitagliptin
• 4G1F: crystal structure of human dipeptidyl peptidase iv in complex with a pyridopyrimidinedione analogue (10.1016/J.BMCL.2012.08.110 )
• 4J3J: crystal structure of dpp-iv with compound c3 (10.1002/CMDC.201300104 )
• 4JH0: crystal structure of dipeptidyl-peptidase 4 (cd26, adenosine deaminase complexing protein 2) (dpp-iv-wt) complex with bms-767778 aka 2-(3- (aminomethyl)-4-(2,4- dichlorophenyl)-2-methyl-5-oxo-5,7-dihydro-6h- pyrrolo[3,4- b]pyridin-6-yl)-n,n-dimethylacetamide (10.1021/JM4008906 )
• 4KR0: complex structure of mers-cov spike rbd bound to cd26 (10.1038/NATURE12328 )
• 4L72: crystal structure of mers-cov complexed with human dpp4 (10.1038/CR.2013.92 )
• 4LKO: crystal structure of human dpp-iv in complex with bms-744891 (10.1021/JM4008906 )
• 4N8D: dpp4 complexed with syn-7aa (10.1016/J.BMCL.2013.12.118 )
• 4N8E: dpp4 complexed with compound 12a (10.1016/J.BMCL.2013.12.118 )
• 4PNZ: human dipeptidyl peptidase iv/cd26 in complex with the long-acting inhibitor omarigliptin (mk-3102) (10.1021/JM401992E )
• 4PV7: cocrystal structure of dipeptidyl-peptidase 4 with an indole scaffold inhibitor (10.1016/J.CCLET.2014.03.047 )
• 4QZV: bat-derived coronavirus hku4 uses mers-cov receptor human cd26 for cell entry (10.1016/J.CHOM.2014.08.009 )
• 5I7U: human dpp4 in complex with a novel tricyclic hetero-cycle inhibitor (10.1021/ACSMEDCHEMLETT.6B00027 )
• 5ISM: human dpp4 in complex with a novel 5,5,6-tricyclic pyrrolidine inhibitor (10.1016/J.BMCL.2016.04.020 )
• 5J3J: crystal structure of human dpp-iv in complex with hl1
• 5KBY: crystal structure of dipeptidyl peptidase iv in complex with syr-472 (10.1371/JOURNAL.PONE.0157509 )
• 5LLS: porcine dipeptidyl peptidase iv in complex with 8-(3-aminopiperidin-1- yl)-7-[(2-bromophenyl)methyl]-1,3-dimethyl-2,3,6,7-tetrahydro-1h- purine-2,6-dione (10.1021/ACS.JMEDCHEM.6B00475 )
• 5T4B: human dpp4 in complex with a ligand 34a (10.1016/J.BMC.2016.09.007 )
• 5T4E: human dpp4 in complex with ligand 19a (10.1016/J.BMC.2016.09.007 )
• 5T4F: human dpp4 in complex with ligand 34p (10.1016/J.BMC.2016.09.007 )
• 5T4H: human dpp4 in complex with ligand 34n (10.1016/J.BMC.2016.09.007 )
• 5VTA: co-crystal structure of dppiv with a chemibody inhibitor (10.1038/S41598-018-25848-0 )
• 5Y7H: crystal structure of human dpp4 in complex with inhibitor3 (10.1016/J.BBRC.2017.10.101 )
• 5Y7J: crystal structure of human dpp4 in complex with inhibitor2 (10.1016/J.BBRC.2017.10.101 )
• 5Y7K: crystal structure of human dpp4 in complex with inhibitor1 (10.1016/J.BBRC.2017.10.101 )
• 5ZID: crystal structure of human dpp-iv in complex with hl2
• 6B1E: the structure of dpp4 in complex with vildagliptin (10.1002/EDM2.2 )
• 6B1O: the structure of dpp4 in complex with vildagliptin analog (10.1002/EDM2.2 )